Literature DB >> 31036344

Three New Cs for CRISPR: Collateral, Communicate, Cooperate.

Andrew Varble1, Luciano A Marraffini2.   

Abstract

Clustered regularly interspaced short palindromic repeats (CRISPR) loci and their associated (cas) genes provide protection against invading phages and plasmids in prokaryotes. Typically, short sequences are captured from the genome of the invader, integrated into the CRISPR locus, and transcribed into short RNAs that direct RNA-guided Cas nucleases to the nucleic acids of the invader for their degradation. Recent work in the field has revealed unexpected features of the CRISPR-Cas mechanism: (i) collateral, nonspecific, cleavage of host nucleic acids; (ii) secondary messengers that amplify the immune response; and (iii) immunosuppression of CRISPR targeting by phage-encoded inhibitors. Here, we review these new and exciting findings.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31036344      PMCID: PMC6525018          DOI: 10.1016/j.tig.2019.03.009

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  97 in total

Review 1.  Initiation of genetic recombination and recombination-dependent replication.

Authors:  S C Kowalczykowski
Journal:  Trends Biochem Sci       Date:  2000-04       Impact factor: 13.807

2.  A DNA repair system specific for thermophilic Archaea and bacteria predicted by genomic context analysis.

Authors:  Kira S Makarova; L Aravind; Nick V Grishin; Igor B Rogozin; Eugene V Koonin
Journal:  Nucleic Acids Res       Date:  2002-01-15       Impact factor: 16.971

3.  The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA.

Authors:  Josiane E Garneau; Marie-Ève Dupuis; Manuela Villion; Dennis A Romero; Rodolphe Barrangou; Patrick Boyaval; Christophe Fremaux; Philippe Horvath; Alfonso H Magadán; Sylvain Moineau
Journal:  Nature       Date:  2010-11-04       Impact factor: 49.962

4.  CRISPR provides acquired resistance against viruses in prokaryotes.

Authors:  Rodolphe Barrangou; Christophe Fremaux; Hélène Deveau; Melissa Richards; Patrick Boyaval; Sylvain Moineau; Dennis A Romero; Philippe Horvath
Journal:  Science       Date:  2007-03-23       Impact factor: 47.728

5.  Cas6 is an endoribonuclease that generates guide RNAs for invader defense in prokaryotes.

Authors:  Jason Carte; Ruiying Wang; Hong Li; Rebecca M Terns; Michael P Terns
Journal:  Genes Dev       Date:  2008-12-15       Impact factor: 11.361

Review 6.  Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.

Authors:  Robert H Silverman
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

7.  RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex.

Authors:  Caryn R Hale; Peng Zhao; Sara Olson; Michael O Duff; Brenton R Graveley; Lance Wells; Rebecca M Terns; Michael P Terns
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

8.  Small CRISPR RNAs guide antiviral defense in prokaryotes.

Authors:  Stan J J Brouns; Matthijs M Jore; Magnus Lundgren; Edze R Westra; Rik J H Slijkhuis; Ambrosius P L Snijders; Mark J Dickman; Kira S Makarova; Eugene V Koonin; John van der Oost
Journal:  Science       Date:  2008-08-15       Impact factor: 47.728

9.  CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA.

Authors:  Luciano A Marraffini; Erik J Sontheimer
Journal:  Science       Date:  2008-12-19       Impact factor: 47.728

10.  Phage response to CRISPR-encoded resistance in Streptococcus thermophilus.

Authors:  Hélène Deveau; Rodolphe Barrangou; Josiane E Garneau; Jessica Labonté; Christophe Fremaux; Patrick Boyaval; Dennis A Romero; Philippe Horvath; Sylvain Moineau
Journal:  J Bacteriol       Date:  2007-12-07       Impact factor: 3.490

View more
  11 in total

1.  Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase.

Authors:  Jinzhong Lin; Mingxia Feng; Heping Zhang; Qunxin She
Journal:  Cell Discov       Date:  2020-05-12       Impact factor: 10.849

2.  A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity.

Authors:  Lucia M Malone; Suzanne L Warring; Simon A Jackson; Carolin Warnecke; Paul P Gardner; Laura F Gumy; Peter C Fineran
Journal:  Nat Microbiol       Date:  2019-12-09       Impact factor: 17.745

3.  High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects.

Authors:  Huawei Tong; Jia Huang; Qingquan Xiao; Bingbing He; Xue Dong; Yuanhua Liu; Xiali Yang; Dingyi Han; Zikang Wang; Xuchen Wang; Wenqin Ying; Runze Zhang; Yu Wei; Chunlong Xu; Yingsi Zhou; Yanfei Li; Minqing Cai; Qifang Wang; Mingxing Xue; Guoling Li; Kailun Fang; Hainan Zhang; Hui Yang
Journal:  Nat Biotechnol       Date:  2022-08-11       Impact factor: 68.164

Review 4.  Development of clustered regularly interspaced short palindromic repeats/CRISPR-associated technology for potential clinical applications.

Authors:  Yue-Ying Huang; Xiao-Yu Zhang; Ping Zhu; Ling Ji
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

Review 5.  The arms race between bacteria and their phage foes.

Authors:  Hannah G Hampton; Bridget N J Watson; Peter C Fineran
Journal:  Nature       Date:  2020-01-15       Impact factor: 49.962

Review 6.  Next-Generation CRISPR Technologies and Their Applications in Gene and Cell Therapy.

Authors:  M Alejandra Zeballos C; Thomas Gaj
Journal:  Trends Biotechnol       Date:  2021-07       Impact factor: 21.942

7.  Structure and mechanism of a Type III CRISPR defence DNA nuclease activated by cyclic oligoadenylate.

Authors:  Stephen A McMahon; Wenlong Zhu; Shirley Graham; Robert Rambo; Malcolm F White; Tracey M Gloster
Journal:  Nat Commun       Date:  2020-01-24       Impact factor: 14.919

Review 8.  The Cyclic Oligoadenylate Signaling Pathway of Type III CRISPR-Cas Systems.

Authors:  Fengtao Huang; Bin Zhu
Journal:  Front Microbiol       Date:  2021-01-20       Impact factor: 5.640

9.  Type I-F CRISPR-Cas resistance against virulent phages results in abortive infection and provides population-level immunity.

Authors:  Bridget N J Watson; Reuben B Vercoe; George P C Salmond; Edze R Westra; Raymond H J Staals; Peter C Fineran
Journal:  Nat Commun       Date:  2019-12-04       Impact factor: 14.919

10.  Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase.

Authors:  Jinzhong Lin; Mingxia Feng; Heping Zhang; Qunxin She
Journal:  Cell Discov       Date:  2020-05-12       Impact factor: 10.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.